US officials head to Berlin for drug pricing talks

A tradução ainda não está pronta. Exibimos o artigo original.

Senior U.S. trade and health officials are expected to meet with the German government in mid-November for talks on its drug pricing policies, a German government spokesperson confirmed to POLITICO. The talks come as Germany races to avoid U.S. tariffs if it does not reach an agreement with Washington — after the Trump administration launched a trade investigation into Berlin’s pricing policies in June. The Trump administration alleges Germany underpays for new drugs, leaving the U.S. to shoulder a disproportionate share of the global cost of developing innovative medicines. As part of consultations required under Section 301 probes, a meeting between U.S.